Phase 2 study for people with Type 2 Diabetes

Not yet recruiting Phase 2

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Not yet recruiting
Phase Phase 2
Sponsor Myopharm Limited
Registry number NCT07139405
Started 1 September 2026 Today 16 October 2026 Estimated completion 1 September 2027

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
UniSC Clinical Trials Maroochydore QLD Status not stated
Momentum Sunshine Melbourne VIC Status not stated
Momentum Darlinghurst Sydney Australia Status not stated

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years to 70 Years
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 48

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria Adults aged 18 to 70 years. Confirmed diagnosis of Type 2 diabetes mellitus. Inadequate glycaemic control while receiving a stable dose of metformin.

Inclusion Criteria:

* Adults aged 18 to 70 years.

* Confirmed diagnosis of Type 2 diabetes mellitus.

* Inadequate glycaemic control while receiving a stable dose of metformin.

* HbA1c within the protocol-defined screening range.

* Body mass index (BMI) 25 to 40 kg/m².

* Adequate renal function.

* Able and willing to provide written informed consent and comply with study procedures.

Exclusion Criteria:

* Type 1 diabetes mellitus or history of diabetic ketoacidosis.

* Use of prohibited glucose-lowering medications before screening.

* Clinically significant renal, hepatic, gastrointestinal, cardiovascular, or other medical conditions that could interfere with study participation or safety.

* Recent major cardiovascular event or unstable cardiovascular disease.

* Previous bariatric surgery or recent treatment with anti-obesity medication.

* Active infection or other uncontrolled medical condition.

* Pregnant or breastfeeding, or unwilling to comply with protocol-required contraception.

* Any condition that, in the investigator's opinion, would make participation unsuitable or compromise the study.

Dates on the record

Started 1 September 2026
Estimated completion 1 September 2027
Registry last updated 8 July 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 8 July 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.